Fabio Calabrò

6PUBLICATIONS
47CO-AUTHORS
Information systems development methodologies and practiceMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 03, 2026
The TOGETHER Model: A Next-Generation Integrated Framework for Communication in Healthcare.

|Jul 29, 2025
Metastatic Melanoma Prognosis Prediction Using a TC Radiomic-Based Machine Learning Model: A Preliminary Study.

Antonino Guerrisi, Maria Teresa Maccallini, Italia Falcone

|Dec 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri

|Sep 28, 2024
Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab.

Rocco Simone Flammia, Gabriele Tuderti, Eugenio Bologna

|Apr 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.

Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud

|Apr 28, 2018
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway.

Ilaria Grazia Zizzari, Chiara Napoletano, Andrea Botticelli

Pageof 1

Frequent Collaborators

1 joint publications

Sara Mokbel

1 joint publications

Richard Cathomas

1 joint publications

Pauline Parent

1 joint publications

Kira-Lee Koster